Guggenheim Reiterates Buy Rating on Cabaletta Bio Inc. (CABA)

November 14, 2024 1:47 PM EST Send to a Friend
Guggenheim analyst Yatin Suneja reiterated a Buy rating and $23.00 price target on Cabaletta Bio Inc. (NASDAQ: CABA).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login